Dissolving microneedles enabled delivery of Oxaliplatin- sodium butyrate loaded outer membrane vesicles against rectal cancer
Abstract Background Oxaliplatin (OXA) is a commonly used drug for the treatment of rectal cancer (RC). However, traditional administration methods are plagued by low efficiency, high systemic side effects, and poor patient tolerance. Therefore, there is an urgent need to develop a targeted drug deli...
Saved in:
| Main Authors: | Chu Jian, Qu Zhanbo, Wu Yinhang, Xu Yating, Huang Bo, Wang Yingchen, Zhuang Jing, Wang Zefeng, Wu Zheng, Yu Xiang, Han Shuwen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-08-01
|
| Series: | Journal of Translational Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12967-025-06921-5 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Short-term and long-term oncological outcomes of chemoradiotherapy for rectal cancer patients with or without oxaliplatin: a propensity score-matched retrospective analysis
by: Amirali Azimi, et al.
Published: (2024-12-01) -
Can Cobalamin prevent Oxaliplatin induced peripheral neuropathy?
by: Naza Shakir Shareef Shekhany, et al.
Published: (2023-06-01) -
Short‐Term Results of the SONCAR Study: Optimized Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer Patients
by: Rongxin Zhang, et al.
Published: (2025-08-01) -
Fabrication and Ex-vivo Evaluation of Olanzapine Nanoparticles Based Dissolved Microneedle for Transdermal Delivery
by: Abulfadhel jaber neamah AL-shaibani, et al.
Published: (2025-06-01) -
Oxaliplatin-induced lung fibrosis
by: Shah Arpan, et al.
Published: (2009-01-01)